Let’s just say the Q2 cc will be interesting The bought deal?
Something they have done before. Was 2018 I believe.
This is the first time in a very long time, they have done "Only in Canada" deal.
Certainly not what I expected, although was in concept when they started coverage with that firm.
We can speculate until the sun goes down as to motivation, plans opportunities?
Good or bad, neither can be verified.
Obviously a 20% hair cut in one morning not good news.
Even @ that. The $15million is not enough to complete a phase 3 trial, let alone 2.trials.
This does howevr create a hypothetical floor for the price.
Like I said, the Q2 update hopefully shines some light on this financing.
They said, an answer regarding the PanCan offer for phase 3 inclusion would be within 90 days.
obviously the bought deal is part of that process.
One thing for sure, with Onc expect the unexpected.